4 reports of this reaction
1.3% of all ACETAMINOPHEN AND IBUPROFEN reports
#13 most reported adverse reaction
MALAISE is the #13 most commonly reported adverse reaction for ACETAMINOPHEN AND IBUPROFEN, manufactured by AFT Pharmaceuticals US, Inc.. There are 4 FDA adverse event reports linking ACETAMINOPHEN AND IBUPROFEN to MALAISE. This represents approximately 1.3% of all 299 adverse event reports for this drug.
Patients taking ACETAMINOPHEN AND IBUPROFEN who experience malaise should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MALAISE is a less commonly reported adverse event for ACETAMINOPHEN AND IBUPROFEN, but still significant enough to appear in the safety profile.
In addition to malaise, the following adverse reactions have been reported for ACETAMINOPHEN AND IBUPROFEN:
The following drugs have also been linked to malaise in FDA adverse event reports:
MALAISE has been reported as an adverse event in 4 FDA reports for ACETAMINOPHEN AND IBUPROFEN. This does not prove causation, but indicates an association observed in post-market surveillance data.
MALAISE accounts for approximately 1.3% of all adverse event reports for ACETAMINOPHEN AND IBUPROFEN, making it a notable side effect.
If you experience malaise while taking ACETAMINOPHEN AND IBUPROFEN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.